The Senate on Wednesday voted 85-14 to defeat an amendment to a spending bill that would have shifted $60 million earmarked for renovations and building construction at the Centers for Disease Control and Prevention to the nation’s AIDS Drug Assistance Programs, Congressional Quarterly Today reports. The amendment, sponsored by Republican senator Tom Coburn of Oklahoma, was defeated after senators from Georgia, which is home to the CDC, fought against it. The CDC funds that would have been redirected to buy lifesaving medications for low-income HIV-positive Americans will instead be used for such projects as building a scenic spot for employees at the agency’s Atlanta grounds that includes a Japanese garden and stream. At least nine ADAPs around the country are facing such severe budget shortfalls that they’ve had to restrict admission to the programs and implement waiting lists. Several others have reduced the number of drugs they provide, tightened financial eligibility requirements, or implemented other cost-saving measures. (Advocate.com)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.